Aflac Incorporated (NYSE:AFL – Get Free Report) major shareholder Post Holdings Co. Ltd. Japan sold 12,900 shares of Aflac stock in a transaction dated Thursday, November 12th. The stock was sold at an average price of $126.99, for a total value of $1,638,171.00. Following the transaction, the insider directly owned 50,095,429 shares in the company, valued at approximately $6,361,618,528.71. The trade was a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Post Holdings Co. Ltd. Japan also recently made the following trade(s):
- On Monday, November 16th, Post Holdings Co. Ltd. Japan sold 19,530 shares of Aflac stock. The stock was sold at an average price of $127.95, for a total value of $2,498,863.50.
- On Friday, November 13th, Post Holdings Co. Ltd. Japan sold 17,000 shares of Aflac stock. The shares were sold at an average price of $127.20, for a total transaction of $2,162,400.00.
- On Tuesday, November 10th, Post Holdings Co. Ltd. Japan sold 13,000 shares of Aflac stock. The shares were sold at an average price of $126.89, for a total transaction of $1,649,570.00.
- On Thursday, October 15th, Post Holdings Co. Ltd. Japan sold 113,611 shares of Aflac stock. The shares were sold at an average price of $118.53, for a total transaction of $13,466,311.83.
- On Wednesday, October 14th, Post Holdings Co. Ltd. Japan sold 55,000 shares of Aflac stock. The stock was sold at an average price of $117.79, for a total transaction of $6,478,450.00.
- On Tuesday, October 13th, Post Holdings Co. Ltd. Japan sold 42,000 shares of Aflac stock. The stock was sold at an average price of $116.38, for a total value of $4,887,960.00.
- On Monday, October 12th, Post Holdings Co. Ltd. Japan sold 12,200 shares of Aflac stock. The stock was sold at an average price of $115.85, for a total value of $1,413,370.00.
- On Friday, October 9th, Post Holdings Co. Ltd. Japan sold 12,000 shares of Aflac stock. The stock was sold at an average price of $114.72, for a total transaction of $1,376,640.00.
- On Thursday, October 8th, Post Holdings Co. Ltd. Japan sold 13,000 shares of Aflac stock. The shares were sold at an average price of $114.45, for a total value of $1,487,850.00.
- On Wednesday, October 7th, Post Holdings Co. Ltd. Japan sold 12,000 shares of Aflac stock. The shares were sold at an average price of $112.80, for a total value of $1,353,600.00.
Aflac Price Performance
AFL opened at $125.24 on Thursday. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.11 and a quick ratio of 0.11. The company has a market capitalization of $61.94 billion, a price-to-earnings ratio of 17.02, a P/E/G ratio of 1.78 and a beta of 0.55. The firm’s fifty day moving average price is $119.14 and its two-hundred day moving average price is $116.91. Aflac Incorporated has a 1 year low of $105.76 and a 1 year high of $131.18.
Aflac Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Wednesday, February 17th will be given a dividend of $0.64 per share. This represents a $2.56 dividend on an annualized basis and a yield of 2.0%. This is a boost from Aflac’s previous quarterly dividend of $0.61. The ex-dividend date is Wednesday, February 17th. Aflac’s dividend payout ratio (DPR) is currently 35.57%.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on AFL shares. Mizuho increased their target price on shares of Aflac from $112.00 to $117.00 and gave the stock an “underperform” rating in a report on Thursday, November 12th. UBS Group reaffirmed a “neutral” rating and issued a $125.00 price target (up from $124.00) on shares of Aflac in a report on Tuesday, October 6th. Weiss Ratings upgraded Aflac from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Tuesday, November 3rd. Wall Street Zen raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Saturday, November 7th. Finally, Wolfe Research initiated coverage on shares of Aflac in a research report on Wednesday, August 19th. They issued an “underperform” rating and a $103.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eight have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $118.73.
View Our Latest Analysis on Aflac
Hedge Funds Weigh In On Aflac
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Groupe la Francaise purchased a new position in shares of Aflac in the 1st quarter valued at approximately $25,000. Archer Investment Corp acquired a new position in shares of Aflac in the 2nd quarter valued at about $26,000. Edmond DE Rothschild Holding S.A. purchased a new position in Aflac in the second quarter valued at about $27,000. Markowski Investments acquired a new stake in Aflac during the 2nd quarter valued at $29,000. Finally, Washington Trust Advisors Inc. acquired a new stake in shares of Aflac during the second quarter worth approximately $29,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Aflac Company Profile
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
See Also
- Five stocks we like better than Aflac
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
